FDA Inspection 1156943 — Fagron, Inc

Fagron, Inc — FEI 1000174332

The FDA completed an inspection of Fagron, Inc on November 18, 2021 in Saint Paul, MN. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 18, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Paul, MN (United States)